Richard Kenney

Company: Sonnet BioTherapeutics Inc.

Job title: Chief Medical Officer

Seminars:

Managing Toxicity Caused by The Over Expression of Cytokines to Widen the Therapeutic Window 11:15 am

Exploring the story behind the introduction of receptor bias to reduce toxicity and improve efficacy Discussing the key strategies for optimizing cytokine potency while mitigating their inherent toxicity while considering the role of the therapeutic index in determining the clinical efficacy and safety of cytokine-based therapies Examining whether toxicity is the primary limiting factor in…Read more

day: Conference Day One